Effect of angiotensin II on iron-transporting protein expression and subsequent intracellular labile iron concentration in human glomerular endothelial cells

Hypertension Research

Volumn 33, Issue 7, 2010, Pages 713-721

  Tajima, Soichiro ^a   Tsuchiya, Koichiro ^a   Horinouchi, Yuya ^a   Ishizawa, Keisuke ^a   Ikeda, Yasumasa ^a   Kihira, Yoshitaka ^a   Shono, Masayuki ^a   Kawazoe, Kazuyoshi ^a   Tomita, Shuhei ^a   Tamaki, Toshiaki ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

angiotensin II; human glomerular microvascular endothelial cells; iron metabolism; labile iron pool; transferrin

Indexed keywords

5,5 DIMETHYL 1 PYRROLINE 1 OXIDE; ANGIOTENSIN II; FERROPORTIN 1; FERROUS ION; HYDROXYL RADICAL; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; OLMESARTAN; TRANSFERRIN; TRANSFERRIN RECEPTOR; CATION TRANSPORT PROTEIN; IRON; METAL TRANSPORTING PROTEIN 1; SOLUTE CARRIER FAMILY 11- (PROTON-COUPLED DIVALENT METAL ION TRANSPORTERS), MEMBER 2;

ARTICLE; CELL LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; GLOMERULUS; HUMAN; HUMAN CELL; IRON METABOLISM; OXIDATION; PROTEIN CARBONYLATION; PROTEIN EXPRESSION; TIME; DRUG EFFECTS; METABOLISM; OXIDATION REDUCTION REACTION;

ANGIOTENSIN II; CATION TRANSPORT PROTEINS; ENDOTHELIAL CELLS; HUMANS; HYDROXYL RADICAL; IRON; KIDNEY GLOMERULUS; OXIDATION-REDUCTION; RECEPTORS, TRANSFERRIN; TRANSFERRIN;

EID: 77954369377     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2010.63     Document Type: Article

References (64)

1. Schmieder RE, Hilgers KF, Schlaich MP, Schmidt BM. Renin-angiotensin system and cardiovascular risk. Lancet 2007; 369: 1208-1219.
2. Ishizaka N, Saito K, Furuta K, Matsuzaki G, Koike K, Noiri E, Nagai R. Angiotensin II-induced regulation of the expression and localization of iron metabolism-related genes in the rat kidney. Hypertens Res 2007; 30: 195-202.
3. Klausner RD, Ashwell G, van Renswoude J, Harford JB, Bridges KR. Binding of apotransferrin to K562 cells: explanation of the transferrin cycle. Proc Natl Acad Sci USA 1983; 80: 2263-2266.
4. Richardson DR, Ponka P. The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells. Biochim Biophys Acta 1997; 1331: 1-40. (Pubitemid 27168147)
5. Armstrong NJ, Morgan EH. The effect of lysosomotrophic bases and inhibitors of transglutaminase on iron uptake by immature erythroid cells. Biochim Biophys Acta 1983; 762: 175-186.
6. Gunshin H, Mackenzie B, Berger UV, Gunshin Y, Romero MF, Boron WF, Nussberger S, Gollan JL, Hediger MA. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 1997; 388: 482-488.
7. Ferguson CJ, Wareing M, Ward DT, Green R, Smith CP, Riccardi D. Cellular localization of divalent metal transporter DMT-1 in rat kidney. Am J Physiol Renal Physiol 2001; 280: F803-F814.
8. Donovan A, Lima CA, Pinkus JL, Pinkus GS, Zon LI, Robine S, Andrews NC. The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab 2005; 1: 191-200.
9. Cairo G, Recalcati S, Pietrangelo A, Minotti G. The iron regulatory proteins: targets and modulators of free radical reactions and oxidative damage. Free Radic Biol Med 2002; 32: 1237-1243.
10. Andrews NC. Probing the iron pool. Focus on 'detection of intracellular iron by its regulatory effect'. Am J Physiol Cell Physiol 2004; 287: C1537-C1538.
11. Kruszewski M. The role of labile iron pool in cardiovascular diseases. Acta Biochim Pol 2004; 51: 471-480.
12. Kakhlon O, Cabantchik ZI. The labile iron pool: characterization, measurement, and participation in cellular processes(1). Free Radic Biol Med 2002; 33: 1037-1046.
13. Yuan X, Cong Y, Hao J, Shan Y, Zhao Z, Wang S, Chen J. Regulation of LIP level and ROS formation through interaction of H-ferritin with G-CSF receptor. J Mol Biol 2004; 339: 131-144.
14. Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 2000; 86: 494-501.
15. Vignais PV. The superoxide-generating NADPH oxidase: structural aspects and activation mechanism. Cell Mol Life Sci 2002; 59: 1428-1459.
16. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994; 74: 1141-1148.
17. Lassegue B, Clempus RE. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol 2003; 285: R277-R297.
18. Kondo S, Shimizu M, Urushihara M, Tsuchiya K, Yoshizumi M, Tamaki T, Nishiyama A, Kawachi H, Shimizu F, Quinn MT, Lambeth DJ, Kagami S. Addition of the antioxidant probucol to angiotensin II type I receptor antagonist arrests progressive mesangiopro-liferative glomerulonephritis in the rat. J Am Soc Nephrol 2006; 17: 783-794.
19. Jones SA, Hancock JT, Jones OT, Neubauer A, Topley N. The expression of NADPH oxidase components in human glomerular mesangial cells: detection of protein and mRNA for p47phox, p67phox, and p22phox. J Am Soc Nephrol 1995; 5: 1483-1491.
20. Kyaw M, Yoshizumi M, Tsuchiya K, Kirima K, Tamaki T. Antioxidants inhibit JNK and p38 MAPK activation but not ERK 1/2 activation by angiotensin II in rat aortic smooth muscle cells. Hypertens Res 2001; 24: 251-261.
21. Rouhanizadeh M, Takabe W, Ai L, Yu H, Hsiai T. Monitoring oxidative stress in vascular endothelial cells in response to fluid shear stress: from biochemical analyses to micro-and nanotechnologies. Methods Enzymol 2008; 441: 111-150.
22. Haber F, Weiss J. The catalytic decomposition of hydrogen peroxide by iron salts. Proc R Soc London, Ser A 1934; 147: 332-351.
23. Symons MCR, Gutteridge JMC. Free Radicals and Iron: Chemistry, Biology, and Medicine. Oxford University Press: New York, 1998.
24. Fridovich I. Oxygen toxicity: a radical explanation. J Exp Biol 1998; 201: 1203-1209.
25. Liochev SI, Fridovich I. The relative importance of HO* and ONOO-in mediating the toxicity of O*. Free Radic Biol Med 1999; 26: 777-778.
26. Thomas CE, Morehouse LA, Aust SD. Ferritin and superoxide-dependent lipid peroxidation. J Biol Chem 1985; 260: 3275-3280.
27. Brieland JK, Fantone JC. Ferrous iron release from transferrin by human neutrophil-derived superoxide anion: effect of pH and iron saturation. Arch Biochem Biophys 1991; 284: 78-83.
28. Seshiah PN, Weber DS, Rocic P, Valppu L, Taniyama Y, Griendling KK. Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circ Res 2002; 91: 406-413.
29. Wesseling S, Ishola Jr DA, Joles JA, Bluyssen HA, Koomans HA, Braam B. Resistance to oxidative stress by chronic infusion of angiotensin II in mouse kidney is not mediated by the AT2 receptor. Am J Physiol Renal Physiol 2005; 288: F1191-F1200.
30. Kohgo Y, Ohtake T, Ikuta K, Suzuki Y, Torimoto Y, Kato J. Dysregulation of systemic iron metabolism in alcoholic liver diseases. J Gastroenterol Hepatol 2008; 23(Suppl 1): S78-S81.
31. Izuhara Y, Nangaku M, Inagi R, Tominaga N, Aizawa T, Kurokawa K, van Ypersele de Strihou C, Miyata T. Renoprotective properties of angiotensin receptor blockers beyond blood pressure lowering. J Am Soc Nephrol 2005; 16: 3631-3641.
32. Hirose A, Ono M, Saibara T, Nozaki Y, Masuda K, Yoshioka A, Takahashi M, Akisawa N, Iwasaki S, Oben JA, Onishi S. Angiotensin II type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis. Hepatology 2007; 45: 1375-1381. (Pubitemid 46918321)
33. Gillum RF, Sempos CT, Makuc DM, Looker AC, Chien CY, Ingram DD. Serum transferrin saturation, stroke incidence, and mortality in women and men. The NHANES I Epidemiologic Follow up Study. National Health and Nutrition Examination Survey. Am J Epidemiol 1996; 144: 59-68.
34. Ponka P, Schulman HM. Acquisition of iron from transferrin regulates reticulocyte heme synthesis. J Biol Chem 1985; 260: 14717-14721.
35. Aisen P. The transferrins. In Jacobs A, Worwood M (eds). Iron in Biochemistry and Medicine, Vol 2. Academic Press: New York, 1974 pp 87-129.
36. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
37. Petrat F, Rauen U, de Groot H. Determination of the chelatable iron pool of isolated rat hepatocytes by digital fluorescence microscopy using the fluorescent probe, phen green SK. Hepatology 1999; 29: 1171-1179.
38. Yoshizumi M, Kogame T, Suzaki Y, Fujita Y, Kyaw M, Kirima K, Ishizawa K, Tsuchiya K, Kagami S, Tamaki T. Ebselen attenuates oxidative stress-induced apoptosis via the inhibition of the c-Jun N-terminal kinase and activator protein-1 signalling pathway in PC12 cells. Br J Pharmacol 2002; 136: 1023-1032.
39. Duling DR. Simulation of multiple isotropic spin-trap EPR spectra. J Magn Reson B 1994; 104: 105-110.
40. Buss H, Chan TP, Sluis KB, Domigan NM, Winterbourn CC. Protein carbonyl measurement by a sensitive ELISA method. Free Radic Biol Med 1997; 23: 361-366.
41. Petrat F, de Groot H, Rauen U. Subcellular distribution of chelatable iron: a laser scanning microscopic study in isolated hepatocytes and liver endothelial cells. Biochem J 2001; 356: 61-69.
42. Floyd RA, Soong LM, Stuart MA, Reigh DL. Spin trapping of free radicals produced from nitrosoamine carcinogens. Photochem Photobiol 1978; 28: 857-862.
43. Andrews NC. Disorders of iron metabolism. N Engl J Med 1999; 341: 1986-1995.
44. Kohgo Y, Ikuta K, Ohtake T, Torimoto Y, Kato J. Body iron metabolism and patho-physiology of iron overload. Int J Hematol 2008; 88: 7-15.
45. Tsung SH, Rosenthal WA, Milewski KA. Immunological measurement of transferrin compared with chemical measurement of total iron-binding capacity. Clin Chem 1975; 21: 1063-1066.
46. Zainal TA, Weindruch R, Szweda LI, Oberley TD. Localization of 4-hydroxy-2-nonenal-modified proteins in kidney following iron overload. Free Radic Biol Med 1999; 26: 1181-1193.
47. Abdel-Razik AE, Forty EJ, Balment RJ, Ashton N. Renal haemodynamic and tubular actions of urotensin II in the rat. J Endocrinol 2008; 198: 617-624.
48. Ikuta K, Zak O, Aisen P. Recycling, degradation and sensitivity to the synergistic anion of transferrin in the receptor-independent route of iron uptake by human hepatoma (HuH-7) cells. Int J Biochem Cell Biol 2004; 36: 340-352.
49. Ishizaka N, Aizawa T, Mori I, Taguchi J, Yazaki Y, Nagai R, Ohno M. Heme oxygenase-1 is upregulated in the rat heart in response to chronic administration of angiotensin II. Am J Physiol Heart Circ Physiol 2000; 279: H672-H678.
50. Miura J, Uchigata Y, Yokoyama H, Omori Y, Iwamoto Y. Genetic polymorphism of renin-angiotensin system is not associated with diabetic vascular complications in Japanese subjects with long-term insulin dependent diabetes mellitus. Diabetes Res Clin Pract 1999; 45: 41-49.
51. Zhang DL, Hughes RM, Ollivierre-Wilson H, Ghosh MC, Rouault TA. A ferroportin transcript that lacks an iron-responsive element enables duodenal and erythroid precursor cells to evade translational repression. Cell Metab 2009; 9: 461-473.
52. Thomson AM, Rogers JT, Leedman PJ. Iron-regulatory proteins, iron-responsive elements and ferritin mRNA translation. Int J Biochem Cell Biol 1999; 31: 1139-1152.
53. Balla J, Jeney V, Varga Z, Komodi E, Nagy E, Balla G. Iron homeostasis in chronic inflammation. Acta Physiol Hung 2007; 94: 95-106.
54. Harrison PM, Arosio P. The ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta 1996; 1275: 161-203.
55. Koorts AM, Viljoen M. Ferritin and ferritin isoforms I: structure-function relationships, synthesis, degradation and secretion. Arch Physiol Biochem 2007; 113: 30-54.
56. Tabuchi M, Yoshimori T, Yamaguchi K, Yoshida T, Kishi F. Human NRAMP2/DMT1, which mediates iron transport across endosomal membranes, is localized to late endosomes and lysosomes in HEp-2 cells. J Biol Chem 2000; 275: 22220-22228.
57. Aizawa T, Ishizaka N, Taguchi J, Nagai R, Mori I, Tang SS, Ingelfinger JR, Ohno M. Heme oxygenase-1 is upregulated in the kidney of angiotensin II-induced hypertensive rats: possible role in renoprotection. Hypertension 2000; 35: 800-806.
58. Courtney AE, Maxwell AP. Heme oxygenase 1: does it have a role in renal cytoprotec-tion? Am J Kidney Dis 2008; 51: 678-690.
59. Mendiburo MJ, Flores S, Pizarro F, Arredondo M. Heme oxygenase 1 overexpression increases iron fluxes in caco-2 cells. Biol Res 2006; 39: 195-197.
60. Blakeman DP, Ryan TP, Jolly RA, Petry TW. Protein oxidation: examination of potential lipid-independent mechanisms for protein carbonyl formation. J Biochem Mol Toxicol 1998; 12: 185-190.
61. Stadtman ER. Metal ion-catalyzed oxidation of proteins: biochemical mechanism and biological consequences. Free Radic Biol Med 1990; 9: 315-325.
62. Kartikasari AE, Georgiou NA, Visseren FL, van Kats-Renaud H, van Asbeck BS, Marx JJ. Intracellular labile iron modulates adhesion of human monocytes to human endothelial cells. Arterioscler Thromb Vasc Biol 2004; 24: 2257-2262.
63. Snover DC. Hepatitis C, iron, and hemochromatosis gene mutations. A meaningful relationship or simple cohabitation? Am J Clin Pathol 2000; 113: 475-478.
64. Franchini M, Targher G, Capra F, Montagnana M, Lippi G. The effect of iron depletion on chronic hepatitis C virus infection. Hepatol Int 2008; 2: 335-340.